Hubei Guangji Pharmaceutical Jikang Medicine Co., Ltd. announced a private placement for gross proceeds of CNY 45 million on July 19, 2022. The transaction included participation from Hubei Guangji Pharmaceutical Co., Ltd. The company issued common shares in the transaction. The transaction has been approved by board of directors of the investor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.9 CNY | +2.97% | +7.27% | -26.16% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.16% | 288M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 000952 Stock
- News Hubei Guangji Pharmaceutical Co., Ltd.
- Hubei Guangji Pharmaceutical Jikang Medicine Co., Ltd. announced that it has received CNY 45 million in funding from Hubei Guangji Pharmaceutical Co., Ltd.